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Abstract: When comparing biological conditions using mass cytometry data, one 
key challenge is to identify cellular populations that change in abundance. Here, we 
present a novel computational strategy for detecting these “differentially abundant” 
populations, by assigning cells to hyperspheres, testing for significant differences 
between conditions and controlling the spatial false discovery rate. The method’s 
performance is established using simulations and real data where it finds novel 
patterns of differential abundance. 
 
Mass cytometry allows researchers to simultaneously characterise the 
expression of many (> 30) protein markers in each of millions of cells1. Antibodies 
specific to markers of interest are conjugated to heavy metal isotopes and used to 
stain a population of cells. Single-cell droplets are formed and vaporized to ionize the 
metals, and the quantity of each isotope bound to each cell is measured by time-of-
flight mass spectrometry. The resolution of mass spectrometry avoids problems with 
spectral overlap that are frequently encountered in conventional flow cytometry with 
fluorescent markers. This means that more markers can be quantified for each cell, 
improving resolution of distinct subpopulations and enabling deep phenotyping of 
cellular profiles in fields such as immunology, haematopoietic development and 
cancer2, 3, 4, 5, 6. The ability of mass cytometry to assay more markers leads to a 
concomitant increase in the dimensionality of the data. This complicates the data 
analysis as manual gating and visual examination of biaxial plots (as commonly used 
in flow cytometry) are no longer feasible when multiple marker combinations have to 
be considered. To address this, bespoke computational tools such as SPADE7 and 
X-shift8 have been developed, focusing on clustering cells into biologically relevant 
subpopulations based on the “intensity” of each marker (i.e., the signal of the 
corresponding isotope in the mass spectrum) and quantifying the abundance of each 
subpopulation in the total cell pool. However, these approaches fail to directly 
address an important question of multiparameter multi-group experiments – namely, 
what differs between groups?  
To this end, an alternative analytical strategy is to identify subpopulations that 
change in abundance between biological conditions9, 10. For example, certain 
immune compartments are enriched or depleted upon drug treatment, and the 
composition of cell types changes during development. Detection of these 
differentially abundant (DA) subpopulations is useful as it can provide insights into 
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the cause or effect of the biological differences between conditions. Existing 
methods for DA analysis cluster cells from all samples into empirical subpopulations, 
before checking each cluster for characteristics (e.g., marker intensities or cell 
abundance) that differ between conditions11, 12. While intuitive, this approach is 
sensitive to the parametrization of the initial clustering step. Uncertainty will be 
introduced into the cluster definitions when the data are noisy or the cells are not 
clearly separated13. This is particularly relevant for markers that are expressed 
across a range of intensities without clear changes in cellular density at 
subpopulation boundaries, such as CD38 and HLA-DR to mark activated T cells or 
CD24 and CD38 to define plasmablasts among B cells14. Ambiguity in clustering can 
affect the performance of the subsequent DA analysis, e.g., if DA and non-DA 
subpopulations are erroneously clustered together.  
Here, we present a novel computational strategy to perform DA analyses of 
mass cytometry data (Figure 1) that does not rely on an initial clustering step. Firstly, 
we assign cells from all samples to hyperspheres in the multi-dimensional marker 
space. Consider a mass cytometry data set with S samples and M markers. Each 
cell in each sample defines a point in the M-dimensional space, with coordinates 
defined by its intensities. We consider M-dimensional hyperspheres where each 
hypersphere is centred on an existing cell and has radius r=0.5ÖM to offset the 
increasing sparsity of the data as the number of dimensions increases. All cells lying 
within a hypersphere are then assigned to that hypersphere. (Each cell can be 
counted multiple times if it is assigned to overlapping hyperspheres.) We count the 
number of cells from each sample assigned to each hypersphere, yielding S counts 
per hypersphere. For each marker, we also compute its median intensity for all cells 
in each hypersphere. This provides a median-based position for the hypersphere, 
representing a central point in M-dimensional space around which most of the cells 
in the hypersphere are located. See Supplementary Note 1, Supplementary Figures 
1-4 and Supplementary Table 1 for more details. We also assume that marker 
intensities are comparable across samples – some strategies for handling sample-
specific intensity shifts are described in Supplementary Note 2 and Supplementary 
Figures 5-6.  
Next, we use the count data for each hypersphere to test for significant 
differences in cell abundance between conditions. The null hypothesis is that there is 
 4 
no change in the average counts between conditions within each hypersphere. 
Testing is performed with negative binomial generalized linear models (NB GLMs), 
which explicitly account for the discrete nature of counts; model overdispersion due 
to biological variability between replicate samples; and can accommodate complex 
experimental designs involving multiple factors and covariates. We use the NB GLM 
implementation in the edgeR package15, which was originally designed for analyzing 
read count data from RNA sequencing experiments. However, the same 
mathematical framework can be applied here to cell counts. In particular, edgeR 
uses empirical Bayes shrinkage to share information across hyperspheres. This 
improves estimation of the dispersion parameter in the presence of limited replicates, 
increasing the reliability and power of downstream inferences. (See Supplementary 
Note 3 and Supplementary Figures 7-8 for more details.) Indeed, edgeR is more 
powerful than the commonly used Mann-Whitney test for detecting differences in 
hypersphere counts in simulated data, while still controlling the type I error rate 
(Supplementary Figure 9).  
Finally, we use the hypersphere p-values to control the false discovery rate 
(FDR) across the multi-dimensional space, i.e., the spatial FDR. To illustrate, 
consider the total volume occupied by the set of DA hyperspheres. (This is a union 
rather than a sum of the hypersphere volumes, due to overlaps between 
hyperspheres.) Roughly speaking, the spatial FDR can be interpreted as the 
proportion of this volume that is occupied by false positive hyperspheres. This is not 
equivalent to the FDR across the individual hyperspheres, due to the differences in 
the density of hyperspheres across the space. For example, the FDR across 
hyperspheres in Figure 1d is 25% while the spatial FDR across volume is 50%. To 
control the spatial FDR, each hypersphere is weighted by the reciprocal of its density 
(calculated in terms of the neighbouring hyperspheres). A weighted version of the 
Benjamini-Hochberg (BH) method16 is then applied to the p-values and weights for 
all hyperspheres. If one were to split the high-dimensional space into non-
overlapping partitions of equal volume, the total weight of hyperspheres within each 
non-empty partition would be similar, i.e., each partition of the space makes a similar 
contribution to the BH correction, regardless of how many hyperspheres it contains. 
Thus, weighting allows the FDR to be controlled across volume, rather than across 
hyperspheres. (See Supplementary Note 4 and Supplementary Figure 10 for a more 
precise description of the spatial FDR.) We demonstrate that our weighting scheme 
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successfully controls the spatial FDR in simulated data, whereas a naïve approach 
without weighting does not (Supplementary Figure 11).  
Several options are available for examining DA hyperspheres after the 
statistical analysis. We can identify significant hyperspheres that are not redundant 
to – i.e., do not lie within a certain distance of – hyperspheres with smaller p-values 
(Supplementary Note 5). The resulting subset of hyperspheres is small enough for 
detailed inspection of the marker intensities with a graphical interface 
(Supplementary Figure 12) to characterise each hypersphere. A complementary 
approach is to perform dimensionality reduction on the positions of the putative DA 
hyperspheres, yielding a low-dimensional representation of the differential 
subspaces for plotting. The plot is annotated based on examination of the marker 
intensities, incorporating biological expertise on the relationships between specific 
markers and cell types. This allows identification of biologically relevant 
subpopulations from the DA hyperspheres.  
We demonstrate our approach using data from a study of mouse embryonic 
fibroblast (MEF) reprogramming17. In this study, three transgenic MEF reporter 
systems (Oct4-GFP, Nanog-GFP or Nanog-Neo) were reprogrammed to induced 
pluripotent stem cells. Samples were collected across various points of the 
reprogramming time course for each MEF reprogramming system. We applied our 
method to each time course to detect changes in abundance over time, defining 
putative DA hyperspheres as those detected at a spatial FDR of 5%. In this manner, 
we detected 7416, 5947 and 21532 DA hyperspheres in the Oct4-GFP, Nanog-GFP 
and Nanog-Neo time courses, respectively. We applied t-SNE18 to the positions of 
detected hyperspheres to visualize them in a spatial context (Figure 2, 
Supplementary Figures 13-18). In the Oct4-GFP analysis, we recovered previously 
identified DA subpopulations, including the three reprogramming end points; as well 
as distinct DA subpopulations that were not clearly characterised in the original 
analysis, such as a subpopulation of SC4-like cells with phosphorylated STAT3, 
AMPK and PLK1 that exhibited a non-linear change in abundance over time 
(Supplementary Figure 19) – see Supplementary Note 6 for details.  
We also applied our method on another data set examining the effect of 
interleukin 10 (IL-10) treatment on bone marrow mononuclear cells (BMMCs) across 
five healthy donors6. Importantly, this data set contained matched stimulated and 
unstimulated samples from each donor. This experimental design is easily 
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accommodated by the GLM machinery in edgeR, highlighting the flexibility of our 
framework. We observed changes in abundance associated with phosphorylated 
STAT3 expression, consistent with the expected biology of IL-10, as well as several 
interesting DA subpopulations that were not identified by the original study (see 
Supplementary Note 7, Supplementary Figures 20-21 for details). More generally, 
shifts in marker intensity for signalling molecules or activation markers will cause 
changes in abundance that can be detected by the DA analysis (Supplementary 
Note 8, Supplementary Figure 22).  
Finally, we compared our approach to CITRUS12, an existing method that 
uses an initial clustering step for comparative analysis of mass cytometry data. We 
simulated a simple scenario involving two adjacent subpopulations with opposite 
changes in abundance between conditions (Supplementary Note 9, Supplementary 
Figure 23). These subpopulations were consistently detected as being differentially 
abundant by our hypersphere-based method but not by CITRUS. We also tested the 
performance of CITRUS for detecting differentially abundant subpopulations across 
time in the MEF reprogramming data set. CITRUS did not detect a number of 
subpopulations that were found by our method (Supplementary Figure 24), nor did it 
detect any new subpopulations. This suggests that the use of hyperspheres, in 
combination with edgeR and the spatial FDR, can improve detection of subtle 
changes in abundance within complex subpopulations that are difficult to cluster.  
As mass cytometry becomes more accessible, large-scale experiments 
containing many conditions and replicates are likely to become increasingly routine. 
Indeed, a growing number of studies are using mass cytometry in fields such as 
immunology, haematopoietic development and cancer. We anticipate that our 
differential abundance analysis pipeline will be useful to researchers planning to 
perform comparative studies with such data sets.  
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Figure legends 
 
Figure 1: Schematic of the differential abundance pipeline. (a) Cells from samples 1 
or 2 are distributed across the multi-dimensional marker space (two markers shown 
here for simplicity). Hyperspheres (yellow, h1-h4) centred on selected cells are 
constructed, and the number of cells from each sample inside each hypersphere is 
counted. (b) Counts for each hypersphere are tested for significant differences 
between samples. This yields a p-value representing the evidence against the null 
hypothesis of no differences. (c) Multiple testing correction of hypersphere p-values 
is performed by controlling the spatial FDR. Positions of significant hyperspheres at 
a given spatial FDR threshold are visualized by dimensionality reduction (e.g., PCA). 
(d) The spatial FDR is roughly equivalent to the proportion of the volume occupied by 
false positive hyperspheres. Each hypersphere has a median-based position (small 
circles) and occupies a volume of the high-dimensional space (shown as the dotted 
ring for two hyperspheres). The total occupied volume is the union of individual 
hypersphere volumes. Two groups of hyperspheres are shown – one containing true 
positives with genuine differences in abundance, the other containing false positives 
– that occupy a similar total volume V with different densities.  
 
Figure 2: Differentially abundant subpopulations in the Oct4-GFP time course, 
detected at a spatial FDR of 5%. (a) A t-SNE plot of the median positions of DA 
hyperspheres. Each point represents a hypersphere and is coloured according to its 
average log-fold change in abundance over time. Grey points represent 
hyperspheres with significant but non-linear changes in abundance. Subpopulations 
were annotated based on results in Zunder et al.17, with additional distinguishing 
features for each subpopulation noted in parentheses. OSKM: reprogramming 
factors (OCT4, SOX2, KLF4, c-MYC), NE: non-expressing, MET: mesenchymal-
epithelial transition, SC4: partially reprogrammed cell line, ESC: embryonic stem 
cells, mixed 4F: mixed stoichiometry of the OSKM factors. (b) The same plots 
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coloured by the median intensity of selected markers in each hypersphere. The 
colour range for each marker was bounded at the 1st and 99th percentiles of the 
intensities across all cells.  
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Online Methods 
 
Data preparation 
In this section, we describe the processing of data from the MEF 
reprogramming study17. For processing of data from the BMMC study6, see 
Supplementary Note 7 for details.  
We obtained de-barcoded flow cytometry standard (FCS) files for each time 
course from Cytobank (accession number 43324). We applied the logicle 
transformation19 to the marker intensities in each sample. The transformation 
parameters were estimated with the estimateLogicle function from the flowCore 
package20, using pooled cells from all samples in each time course. (This avoids 
spurious differences from sample-specific transformation.) We gated out cell events 
with low intensities for the two DNA markers (Iridium-191 and 193), where the 
threshold was defined as three median absolute deviations below the median 
intensity for the pooled cells. We saved the transformed and gated intensities into 
new FCS files for processing with our pipeline. Only the intensities for relevant 
markers (i.e., no DNA, barcodes) were used for further analysis. Note that 
normalization of marker intensities between samples is not required for this data set 
because the samples in each time course were barcoded and pooled for antibody 
staining and mass cytometry.  
 
Statistical methods for testing differences 
To compute p-values, hypersphere counts were analyzed using the quasi-
likelihood (QL) method in edgeR. First, we filtered out hyperspheres with an average 
count below 5. This improves efficiency by removing tests without enough 
information to reject the null hypothesis. For the remaining hyperspheres, we fitted a 
mean-dependent trend to the NB dispersion estimates. We fitted a NB GLM to the 
counts for each hypersphere, using the trended dispersion for each hypersphere and 
the log-transformed total number of cells as the offset for each sample. We 
estimated the QL dispersion from the GLM deviance and stabilized the estimates by 
empirical Bayes shrinkage towards a second mean-dependent trend. Finally, we 
used the QL F-test with a specified contrast to compute a p-value for each 
hypersphere. Details of the statistical framework are provided in Supplementary Note 
3.  
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For the time course analyses, we used a design matrix constructed from a B-
spline basis matrix with a time covariate and 3 degrees of freedom. This provided 9, 
11 and 10 residual degrees of freedom for dispersion estimation in the Oct4-GFP, 
Nanog-GFP and Nanog-Neo data sets, respectively. Contrasts were constructed to 
test whether all spline coefficients were equal to zero. This represents a null 
hypothesis that time has no effect on abundance. The use of splines accommodates 
both linear and non-linear trends in abundance with respect to time. 
  
Visualizing the differential hyperspheres 
For each hypersphere detected at a spatial FDR of 5%, we defined the 
median-based position as a set of intensity values across all markers. These values 
were used to perform t-SNE via the Rtsne package (https://cran.r-
project.org/web/packages/Rtsne), using a perplexity value of 10. To colour the plot 
based on differential abundance, a GLM was fitted to the counts for each 
hypersphere using a design matrix with time as a covariate. This yields a log2-fold 
change in abundance per day for each hypersphere, corresponding to a blue-to-red 
gradient for negative-to-positive values respectively. (We assume a linear change in 
abundance over time for simplicity. This does not affect the significance statistics, 
which are computed with a spline to account for non-linear trends.) To colour the plot 
based on marker intensity, the 1st and 99th percentiles of the intensities for all cells 
were computed for each marker. A linear gradient between these two percentiles 
was constructed using the viridis colour scheme (https://cran.r-
project.org/web/packages/viridis). Each hypersphere was then assigned a colour 
based on the location of its median marker intensity on the gradient.  
 
Using CITRUS to analyze the MEF data 
To run CITRUS (v0.08), the citrus.full command was used with the 
featureType argument set to “abundances” and the modelType argument set to 
“sam”. The family argument was set to “continuous” to identify changes in 
abundance over time. Downsampling was performed to 1000 cells per sample and 
the minimum cluster size was set to 5%, based on the default settings. Detected 
clusters were defined as those reported at a FDR of 5%, as reported by the SAM 
method. For each detected cluster, the median-based centre was determined and 
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the hypersphere with the closest position to the cluster centre in M-dimensional 
space was identified. Each cluster centre was mapped onto the t-SNE plot of DA 
hyperspheres using the coordinates of its closest hypersphere. Note that a cluster 
centre was not mapped if the distance to the closest hypersphere was greater than 
0.5√M. If an unmapped DA cluster was present, it was treated as being undetected 
by the hypersphere-based approach.  
 
Implementation of cell counting software 
All simulation and analysis code were written in R. Methods in the cydar 
package were written in a combination of R and C++. Cell counting, nearest-
neighbour detection and density estimation were performed using an approach 
similar to that in X-shift8. Briefly, k-means clustering was performed on all cells, 
setting k = √N where N  is the total number of cells. Let |j – t| denote the Euclidean 
distance between cell j and the centre of cluster t in the M-dimensional marker 
space. Similarly, let |h − t| denote the distance between the centres of t and 
hypersphere h. Both of these distances only need to be computed once per cell – in 
the latter case, this is because each hypersphere is centred on a cell. By applying 
the triangle inequality, a cell j in cluster t was only considered for assignment to a 
hypersphere h if r + |j − t| ≥ |h − t|. For cells not satisfying this requirement, the 
distance between j and h was not computed to avoid unnecessary work. Similarly, j 
was only considered as a possible neighbour of a cell j' if dn + |j − t| ≥ |j' - t| where dn 
is the distance to the current nth nearest neighbour (where the value of dn is 
continually updated once a closer nth nearest neighbour is identified). This speeds up 
the pipeline while yielding the same results as a naïve approach that computes 
distances between every pair of cells. On a desktop machine, the analysis takes 10-
20 minutes to run for each of the MEF reprogramming time courses.  
 
Code availability  
Simulation and analysis code are accessible at 
http://github.com/MarioniLab/DAMethods2016. Methods in the DA analysis pipeline 
are publicly available in the cydar package (mass CYtometry for Differential 
Abundance analyses in R) from the open-source Bioconductor project at 
http://bioconductor.org/packages/cydar, or by downloading the Supplementary 
Software associated with this paper.  
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Data availability  
All data sets used here are publicly available from Cytobank 
(https://community.cytobank.org), using the accession number 43324 for the MEF 
study and 44185 for the BMMC study.  
 
 
Supplementary Materials  
The Supplementary Materials is a single PDF file that consists of Sections 1-9 and 
contains Supplementary Figures 1-24 and Supplementary Table 1.  
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